Literature DB >> 8086541

Cholestatic hepatitis in a patient who received clarithromycin therapy for a Mycobacterium chelonae lung infection.

W W Yew, C H Chau, J Lee, C W Leung.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8086541     DOI： 10.1093/clinids/18.6.1025

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  5 in total

Review 1.  Comparative tolerability of erythromycin and newer macrolide antibacterials in paediatric patients.

Authors:  N Principi; S Esposito
Journal:  Drug Saf       Date:  1999-01       Impact factor: 5.606

Review 2.  Clarithromycin. A review of its efficacy in the treatment of respiratory tract infections in immunocompetent patients.

Authors:  H D Langtry; R N Brogden
Journal:  Drugs       Date:  1997-06       Impact factor: 9.546

Review 3.  Hepatic safety of antibiotics used in primary care.

Authors:  Raúl J Andrade; Paul M Tulkens
Journal:  J Antimicrob Chemother       Date:  2011-05-17       Impact factor: 5.790

4.  Sudden elevation of liver enzymes in a 64-year-old patient: a case report.

Authors:  Marcus Wiedmann; Constanze Müller; Hartmut Lobeck; Katharina Wölke
Journal:  Cases J       Date:  2009-11-18

5.  Clarithromycin-Associated Acute Liver Failure Leading to Fatal, Massive Upper Gastrointestinal Hemorrhage from Profound Coagulopathy: Case Report and Systematic Literature Review.

Authors:  Ahmed I Edhi; Seifeldin Hakim; Christienne Shams; Damanpreet Bedi; Mitual Amin; Mitchell S Cappell
Journal:  Case Reports Hepatol       Date:  2020-02-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.